Enrollment is completed in a late-stage anaesthesiology trial

Close-out visits are scheduled to be performed by GCT team in Russia for a Phase III multi-center double-blind anaesthesiology study sponsored by a leading Russian pharmaceutical company.

120 patients were enrolled and received study treatment within aggressive timelines. The completion of the enrollment is an important milestone for the clinical program aimed at bringing an anaesthetic to the market.

GCT is contracted to provide overall project management, LEC submissions, site contracting, clinical monitoring, safety reporting, data management, biostatistics and final report preparation.

GCT приступает к проведению визитов закрытия в рамках многоцентрового исследования 3 фазы.  120 пациентов были включены в исследование в сроки, установленные спонсором, – ведущей российской фармацевтической компанией.

В рамках данного исследования компания GCT предоставляет услуги по управлению проектом, разработке и подписанию контрактов с исследовательскими центрами и ЛЭК, клиническому мониторингу, обработке информации о СНЯ, управлению данными, биостатистике и разработке финального отчета.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.